Advanced search×

Sporadic breast cancer patients' germline DNA exhibit an AT-rich microsatellite signature.

Genes Chromosomes Cancer 50(4):275-83 (2011) PMID 21240973

Using a custom CGH-like oligonucleotide array to measure the global microsatellite content in the genomes of 72 cancer, cancer-free, and high risk patient and cell line samples (56 germline DNA and 16 in tumor or tumor cell line DNA) we found a unique, reproducible, and statistically significant pattern of 18 motif-specific microsatellite families (out of 962 possible 1-6 mer repeats) in breast cancer patient germline and tumor DNA, but not in germline DNA of cancer-free volunteer controls or in breast cancer patients with BRCA1/2 mutations. These high-similarity A/T rich repetitive motifs were also more pronounced in the germlines and tumors of colon cancer tumor patients (3/6 samples) and microsatellite unstable colon cancer cell lines; however, germline DNA of sporadic breast cancer patients exhibited the largest global content shift for those motifs with extreme AT/GC ratios. These results indicate that global microsatellite variability is complex, suggest the existence of a previously unknown genomic destabilization mechanism in breast cancer patients' germline DNA, and warrant further testing of such microsatellite variability as a predictor of future breast cancer development.

DOI: 10.1002/gcc.20853
Version: za2963e q8za6 q8zbf q8zce q8zd3 q8ze8 q8zfe q8zge

Similar articles you may find interesting…

  1. Long-Term Outcomes of Failed Prosthetic Breast Reconstruction.

    Ann Plast Surg (2013) PMID 23676517

    After failed prosthetic breast reconstruction, a second attempt with an implant in properly selected patients has a high success rate (92.3%)....
  2. Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin use.

    Breast Cancer Res Treat (2013) PMID 23649190

    We analyzed the use of beta-blockers and ACEIs after a breast cancer diagnosis and their association with breast cancer mortality, both individually, combined with each other, and in combination with aspirin use in the Nurses' Health Study, using updated measures of medication use and Cox proportion...
  3. BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.

    Genes Chromosomes Cancer (2013) PMID 23650027

    The serine/threonine-protein kinase B-raf (BRAF) is an oncogene mutated in various neoplasms, including 5-15% of colorectal carcinomas. The T1799A point mutation, responsible for a large majority of these alterations, results in an amino acid substitution (V600E) causing the constitu...